Your browser doesn't support javascript.
loading
Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A4 Mimetics (QNX-sLXms).
de Gaetano, Monica; Tighe, Catherine; Gahan, Kevin; Zanetti, Andrea; Chen, Jianmin; Newson, Justine; Cacace, Antonino; Marai, Mariam; Gaffney, Andrew; Brennan, Eoin; Kantharidis, Phillip; Cooper, Mark E; Leroy, Xavier; Perretti, Mauro; Gilroy, Derek; Godson, Catherine; Guiry, Patrick J.
Afiliação
  • de Gaetano M; School of Medicine, Diabetes Complications Research Centre, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.
  • Tighe C; Centre for Synthesis and Chemical Biology, School of Chemistry, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.
  • Gahan K; Centre for Synthesis and Chemical Biology, School of Chemistry, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.
  • Zanetti A; Centre for Synthesis and Chemical Biology, School of Chemistry, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.
  • Chen J; William Harvey Research Institute, Queen Mary University London, London EC1M 6BQ, U.K.
  • Newson J; Centre for Clinical Pharmacology, University College London, London WC1E 6JF, U.K.
  • Cacace A; School of Medicine, Diabetes Complications Research Centre, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.
  • Marai M; School of Medicine, Diabetes Complications Research Centre, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.
  • Gaffney A; School of Medicine, Diabetes Complications Research Centre, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.
  • Brennan E; School of Medicine, Diabetes Complications Research Centre, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.
  • Kantharidis P; Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
  • Cooper ME; Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
  • Leroy X; Domain Therapeutics SA, 67400 Strasbourg, Illkirch, France.
  • Perretti M; William Harvey Research Institute, Queen Mary University London, London EC1M 6BQ, U.K.
  • Gilroy D; Centre for Clinical Pharmacology, University College London, London WC1E 6JF, U.K.
  • Godson C; School of Medicine, Diabetes Complications Research Centre, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.
  • Guiry PJ; Centre for Synthesis and Chemical Biology, School of Chemistry, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.
J Med Chem ; 64(13): 9193-9216, 2021 07 08.
Article em En | MEDLINE | ID: mdl-34138563
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinoxalinas / Anti-Inflamatórios não Esteroides / Receptores de Lipoxinas / Receptores de Formil Peptídeo Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Animals / Humans Idioma: En Revista: J Med Chem Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinoxalinas / Anti-Inflamatórios não Esteroides / Receptores de Lipoxinas / Receptores de Formil Peptídeo Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Animals / Humans Idioma: En Revista: J Med Chem Ano de publicação: 2021 Tipo de documento: Article